IE
PRCT icon

Israel Englander’s Procept Biorobotics PRCT Stock Holding History

Israel Englander’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-170,000
Closed -$6.07M – 6360
2025
Q3 		$6.07M Buy
+170,000
New +$7.76M ﹤0.01% 2933
2024
Q4 		– Sell
-40,000
Closed -$3.2M – 6355
2024
Q3 		$3.2M Buy
+40,000
New +$2.84M ﹤0.01% 3240
2023
Q2 		– Sell
-10,000
Closed -$284K – 6565
2023
Q1 		$284K Buy
+10,000
New +$353K ﹤0.01% 4947

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Israel Englander's PRCT Position: Q2 2026 in Review

Israel Englander reduced its Procept Biorobotics (PRCT) stake by 38% in Q2 2026, selling an estimated $9.54M and leaving 624,312 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #1956.

Israel Englander first reported a position in PRCT in Q3 2021 and has held it in 16 quarters since. The position peaked at $31.6M in Q1 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Israel Englander held 624,312 shares of Procept Biorobotics worth $14.1M as of Q2 2026.
  • Israel Englander sold 381,146 Procept Biorobotics shares in Q2 2026, an estimated $9.54M.
  • Procept Biorobotics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1956 holding.
  • Israel Englander first reported a position in Procept Biorobotics in Q3 2021 and has held it in 16 quarters since.
  • Israel Englander's Procept Biorobotics position peaked at $31.6M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.